vs
BICYCLE THERAPEUTICS PLC（BCYC）与Planet Labs PBC（PL）财务数据对比。点击上方公司名可切换其他公司
Planet Labs PBC的季度营收约是BICYCLE THERAPEUTICS PLC的1.7倍（$81.3M vs $48.0M），BICYCLE THERAPEUTICS PLC净利率更高（-42.0% vs -72.8%，领先30.8%），BICYCLE THERAPEUTICS PLC同比增速更快（1193.3% vs 32.6%），Planet Labs PBC自由现金流更多（$1.9M vs $-19.9M），过去两年BICYCLE THERAPEUTICS PLC的营收复合增速更高（56.7% vs 17.5%）
Bicycle Therapeutics是一家临床阶段生物制药企业，专注于开发双环肽类创新疗法以解决未被满足的医疗需求，核心管线覆盖肿瘤、罕见病与免疫疾病领域，在欧美布局运营，与全球头部药企达成战略合作推进候选药物落地。
Planet Labs PBC（常简称为Planet）是总部位于美国加利福尼亚州旧金山的上市地球影像企业，核心目标是实现全球范围的每日成像，以此监测地表变化、精准识别相关趋势，为多行业的地理数据分析需求提供可靠的数据支持。
BCYC vs PL — 直观对比
营收规模更大
PL
是对方的1.7倍
$48.0M
营收增速更快
BCYC
高出1160.7%
32.6%
净利率更高
BCYC
高出30.8%
-72.8%
自由现金流更多
PL
多$21.8M
$-19.9M
两年增速更快
BCYC
近两年复合增速
17.5%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $48.0M | $81.3M |
| 净利润 | $-20.2M | $-59.2M |
| 毛利率 | — | 57.3% |
| 营业利润率 | -51.5% | -22.6% |
| 净利率 | -42.0% | -72.8% |
| 营收同比 | 1193.3% | 32.6% |
| 净利润同比 | 61.1% | -194.7% |
| 每股收益（稀释后） | $-0.29 | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCYCPL
| Q4 25 | $48.0M | $81.3M | ||
| Q3 25 | $11.7M | $73.4M | ||
| Q2 25 | $2.9M | $66.3M | ||
| Q1 25 | $10.0M | $61.6M | ||
| Q4 24 | $3.7M | $61.3M | ||
| Q3 24 | $2.7M | $61.1M | ||
| Q2 24 | $9.4M | $60.4M | ||
| Q1 24 | $19.5M | $58.9M |
净利润BCYCPL
| Q4 25 | $-20.2M | $-59.2M | ||
| Q3 25 | $-59.1M | $-22.6M | ||
| Q2 25 | $-79.0M | $-12.6M | ||
| Q1 25 | $-60.8M | $-35.2M | ||
| Q4 24 | — | $-20.1M | ||
| Q3 24 | $-50.8M | $-38.7M | ||
| Q2 24 | $-39.8M | $-29.3M | ||
| Q1 24 | $-26.6M | $-30.1M |
毛利率BCYCPL
| Q4 25 | — | 57.3% | ||
| Q3 25 | — | 57.6% | ||
| Q2 25 | — | 55.2% | ||
| Q1 25 | — | 62.1% | ||
| Q4 24 | — | 61.2% | ||
| Q3 24 | — | 52.9% | ||
| Q2 24 | — | 52.4% | ||
| Q1 24 | — | 55.2% |
营业利润率BCYCPL
| Q4 25 | -51.5% | -22.6% | ||
| Q3 25 | -558.6% | -24.5% | ||
| Q2 25 | -2965.8% | -34.4% | ||
| Q1 25 | -703.7% | -31.5% | ||
| Q4 24 | — | -36.9% | ||
| Q3 24 | -2385.9% | -64.8% | ||
| Q2 24 | -498.3% | -57.2% | ||
| Q1 24 | -162.4% | -57.6% |
净利率BCYCPL
| Q4 25 | -42.0% | -72.8% | ||
| Q3 25 | -503.7% | -30.8% | ||
| Q2 25 | -2703.8% | -19.1% | ||
| Q1 25 | -608.9% | -57.1% | ||
| Q4 24 | — | -32.8% | ||
| Q3 24 | -1898.4% | -63.3% | ||
| Q2 24 | -425.3% | -48.5% | ||
| Q1 24 | -136.0% | -51.1% |
每股收益（稀释后）BCYCPL
| Q4 25 | $-0.29 | $-0.19 | ||
| Q3 25 | $-0.85 | $-0.07 | ||
| Q2 25 | $-1.14 | $-0.04 | ||
| Q1 25 | $-0.88 | $-0.12 | ||
| Q4 24 | — | $-0.07 | ||
| Q3 24 | $-0.74 | $-0.13 | ||
| Q2 24 | $-0.77 | $-0.10 | ||
| Q1 24 | $-0.62 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $628.1M | $443.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $610.0M | $349.6M |
| 总资产 | $717.6M | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCYCPL
| Q4 25 | $628.1M | $443.3M | ||
| Q3 25 | $648.3M | $181.1M | ||
| Q2 25 | $721.5M | $133.5M | ||
| Q1 25 | $793.0M | $118.0M | ||
| Q4 24 | $879.5M | $139.0M | ||
| Q3 24 | $890.9M | $148.3M | ||
| Q2 24 | $961.4M | $107.4M | ||
| Q1 24 | $457.0M | $83.9M |
总债务BCYCPL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $30.9M | — | ||
| Q1 24 | $30.8M | — |
股东权益BCYCPL
| Q4 25 | $610.0M | $349.6M | ||
| Q3 25 | $618.5M | $435.7M | ||
| Q2 25 | $668.9M | $444.8M | ||
| Q1 25 | $740.3M | $441.3M | ||
| Q4 24 | $793.1M | $464.6M | ||
| Q3 24 | $831.0M | $473.2M | ||
| Q2 24 | $873.8M | $500.3M | ||
| Q1 24 | $356.0M | $518.0M |
总资产BCYCPL
| Q4 25 | $717.6M | $1.1B | ||
| Q3 25 | $764.0M | $696.4M | ||
| Q2 25 | $832.2M | $658.4M | ||
| Q1 25 | $883.9M | $633.8M | ||
| Q4 24 | $956.9M | $630.8M | ||
| Q3 24 | $996.7M | $658.4M | ||
| Q2 24 | $1.1B | $674.6M | ||
| Q1 24 | $547.1M | $702.0M |
负债/权益比BCYCPL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.04× | — | ||
| Q1 24 | 0.09× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.3M | $28.6M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $1.9M |
| 自由现金流率自由现金流/营收 | -41.5% | 2.3% |
| 资本支出强度资本支出/营收 | 1.2% | 32.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-252.0M | $40.7M |
8季度趋势，按日历期对齐
经营现金流BCYCPL
| Q4 25 | $-19.3M | $28.6M | ||
| Q3 25 | $-71.2M | $67.8M | ||
| Q2 25 | $-72.8M | $17.3M | ||
| Q1 25 | $-86.4M | $-6.3M | ||
| Q4 24 | $-164.7M | $4.1M | ||
| Q3 24 | $-39.8M | $-7.9M | ||
| Q2 24 | $-44.6M | $-4.3M | ||
| Q1 24 | $-70.9M | $-6.8M |
自由现金流BCYCPL
| Q4 25 | $-19.9M | $1.9M | ||
| Q3 25 | $-71.8M | $47.5M | ||
| Q2 25 | $-73.3M | $9.2M | ||
| Q1 25 | $-87.0M | $-17.9M | ||
| Q4 24 | $-166.0M | $-3.6M | ||
| Q3 24 | $-40.3M | $-23.0M | ||
| Q2 24 | $-45.0M | $-14.2M | ||
| Q1 24 | $-70.9M | $-15.7M |
自由现金流率BCYCPL
| Q4 25 | -41.5% | 2.3% | ||
| Q3 25 | -612.3% | 64.7% | ||
| Q2 25 | -2509.7% | 13.9% | ||
| Q1 25 | -871.7% | -29.1% | ||
| Q4 24 | -4475.7% | -5.8% | ||
| Q3 24 | -1504.7% | -37.6% | ||
| Q2 24 | -481.2% | -23.6% | ||
| Q1 24 | -362.9% | -26.7% |
资本支出强度BCYCPL
| Q4 25 | 1.2% | 32.9% | ||
| Q3 25 | 5.7% | 27.6% | ||
| Q2 25 | 17.1% | 12.3% | ||
| Q1 25 | 6.1% | 18.9% | ||
| Q4 24 | 33.3% | 12.5% | ||
| Q3 24 | 16.3% | 24.8% | ||
| Q2 24 | 4.5% | 16.4% | ||
| Q1 24 | 0.1% | 15.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCYC
暂无分部数据
PL
| Defense And Intelligence | $49.4M | 61% |
| Civil Government | $18.8M | 23% |
| Commercial | $13.1M | 16% |
